AKT1 and cancer: The enriched mRNA were enriched into various candidate pathways including pathways in cancer (FDR = 1.14 × 10−4), PI3K-Akt signaling pathway (FDR = 4.05 × 10−4), and focal adhesion (FDR = 1.06 × 10−3).